Free Trial

Definitive Healthcare (DH) Earnings Date, Estimates & Call Transcripts

Definitive Healthcare logo
$4.08
-0.10 (-2.39%)
(As of 11/4/2024 ET)

Definitive Healthcare Latest Earnings Summary

Upcoming Q3
Earnings Date
Nov. 7After Market ClosesConfirmed
Actual EPS
(Aug. 5)
$0.09 Beat By $0.00
Consensus EPS
(Aug. 5)
$0.09

Definitive Healthcare issued Q2 2024 earnings on August 5, 2024, reporting an EPS of $0.09, which beat the consensus estimate of $0.09 by $0.00. Quarterly revenue rose 4.4% year-over-year to $63.70 million, above the consensus estimate of $63.19 million. With a trailing EPS of -$3.48, Definitive Healthcare's earnings are expected to grow 28.57% next year, from $0.07 to $0.09 per share.

DH Upcoming Earnings

Definitive Healthcare's next earnings date is scheduled for Thursday, November 7, 2024, with a conference call scheduled for at 5:00 PM ET. Interested parties can register for or listen to the call or dial in at 757-849-6722 with passcode "1765#".

Get Definitive Healthcare Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Definitive Healthcare and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Definitive Healthcare Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.01$0.01$0.010.070 - 0.080
Q2 20241$0.01$0.01$0.010.090 - 0.090
Q3 20241$0.02$0.02$0.020.070 - 0.080
Q4 20241$0.02$0.02$0.02 
FY 20244$0.06$0.06 $0.06

Definitive Healthcare Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/7/2024
(Confirmed)
-------  
8/5/2024Q2 2024$0.0860$0.09+$0.0040$1.87$63.19M$63.70M        
5/7/2024Q1 2024$0.02-$0.02 -$0.04$0.04$64.00M$63.48M    
2/28/2024Q4 2023$0.01-$0.01 -$0.02$0.07$66.01M$65.93M    
11/2/2023Q3 2023$0.02$0.01 -$0.01$1.52$63.60M$65.33M    
8/14/2023Q2 2023$0.0510$0.08+$0.0290$0.08$61.00M$60.96M    
5/4/2023Q1 2023--$0.02 -$0.02$0.07$57.51M$59.20M    
2/23/2023Q4 2022-$0.01$0.01+$0.02-$0.05$58.61M$60.60M    

Definitive Healthcare Earnings - Frequently Asked Questions

Definitive Healthcare has confirmed that its next quarterly earnings data will be published on Thursday, November 7th, 2024. Learn more on DH's earnings history.

In the previous quarter, Definitive Healthcare (NASDAQ:DH) reported $0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.09 by $0.00. Learn more on analysts' earnings estimate vs. DH's actual earnings.

The conference call for Definitive Healthcare's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Definitive Healthcare's latest earnings report can be read online.
Read Transcript

Definitive Healthcare (NASDAQ:DH) has a recorded annual revenue of $251.41 million.

Definitive Healthcare (NASDAQ:DH) has a recorded net income of -$202.39 million. DH has generated -$3.48 earnings per share over the last four quarters.

Definitive Healthcare (NASDAQ:DH) has a forward price-to-earnings ratio of 58.29. The price/earnings-to-growth ratio is 6.1.

Definitive Healthcare's earnings are expected to grow from $0.07 per share to $0.09 per share in the next year, which is a 28.57% increase.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:DH) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners